Literature DB >> 23954249

Renal mass biopsy: "just do it".

Michael Ordon1, Jaime Landman.   

Abstract

Mesh：

Year:  2013        PMID： 23954249     DOI： 10.1016/j.juro.2013.08.013

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

Review 1.  Update on Renal Mass Biopsy.

Authors:  Miki Haifler; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2017-04       Impact factor: 3.092

2.  Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.

Authors:  Mark W Ball; Michael A Gorin; Sam B Bhayani; Craig G Rogers; Michael D Stifelman; Jihad H Kaouk; Homayoun Zargar; Susan Marshall; Jeffrey A Larson; Haider M Rahbar; Bruce J Trock; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-12-11       Impact factor: 3.498

3.  A single-centre experience with tumour tract seeding associated with needle manipulation of renal cell carcinomas.

Authors:  Aravind Viswanathan; Johann P Ingimarsson; John D Seigne; Alan R Schned
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

4.  To stage or not to stage: determining the true clinical significance of the biopsy tract through perinephric fat in assessing renal cell carcinoma.

Authors:  Aida Valencia-Guerrero; Esther Oliva; Chin-Lee Wu; Shulin Wu; Travis Rice-Stitt; Peter M Sadow; Douglas M Dahl; Adam S Feldman; Ronald S Arellano; Kristine M Cornejo
Journal:  Histopathology       Date:  2021-04-19       Impact factor: 7.778

5.  Integrin α5 triggers the metastatic potential in renal cell carcinoma.

Authors:  Dirk Prawitt; Walburgis Brenner; Ines Breuksch; Franz Prosinger; Fabian Baehr; Franz-Peter Engelhardt; Heide-Katharina Bauer; Joachim W Thüroff; Anne-Sophie Heimes; Annette Hasenburg
Journal:  Oncotarget       Date:  2017-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.